Abstract
To optimize outcomes associated with cutaneous procedures the surgeon must consider multiple factors. Many of these factors should be addressed prior to the start of surgery and others require attention during or after the procedure. Recognition of these factors can aid in the meticulous planning and attention to detail necessary to obtain the best outcome following surgical treatment of skin cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Procedure Survey. Dermasurgery Trends and Statistics. Rolling Meadows, IL: American Society for Dermatologic Surgery; 2005. Available from: http://www.asds.net/TheAmericanSocietyforDermatologicSurgeryReleasesNewProcedureSurveyData.aspx. Last accessed February 3, 2009.
Kaplan AL, Weitzul SB, Taylor RS. Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery. Dermatol Surg. 2008;34:15–19.
Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol. 1998;39:698–703.
Kovich O, Otley CC. Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practice. Dermatol Surg. 2002;28:513–517.
Otley CC. Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc. 2003;78:1392–1396.
Alcalay J, Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue? Dermatol Surg. 2004;30:1091–1094.
Schanbacker CF, Bennett RG. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg. 2000;26:785–789.
Alam M, Goldberg LH. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg. 2002;28992–998.
Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol. 2003;48:233–237.
Chang LK, Whitaker DC. The impact of herbal medicines on dermatologic surgery. Dermatol Surg. 2001;27:759–763.
Timbo BB, Ross MP, McCarthy PV, et al. Dietary supplements in a national survey: Prevalence of use and reports of adverse events. J Am Diet Assoc. 2006;106:1966–1974.
Cox AC, Rao GH, Gerrard JM, White JG. The influence of vitamin E quinone on platelet structure, function, and biochemistry. Blood. 1980;55:907–914.
Ziv O, Ragni MV. Bleeding manifestations in males with von Willebrand disease. Haemophilia. 2004;10:162–168.
Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993;123:893–898.
Leonard AL, Hanke CW, Greist A. Perioperative management of von Willebrand disease in dermatologic surgery. Dermatol Surg. 2007;33:403–409.
Nichols WC, Ginsburg D. Von Willebrand disease. Medicine (Baltimore ). 1997;76:1–20.
Bailey BJ, Johnson JT, Newlands SD. Head & Neck Surgery—Otolaryngology. Philadelphia: Lippincott Williams & Wilkins; 2006:217.
Busti AJ, Hooper JS, Amaya CJ, Kazi S. Effects of perioperative anti-inflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy. 2005;25:1566–1591.
Abdelmalek M, Spencer J. Retinoids and wound healing. Dermatol Surg. 2006;32:1219–1230.
Taniguchi Y, Shimizu Y, Inachi S, Shimizu M. Skin surgery in patients 90 years of age and over. Int J Dermatol. 1998;37:547–550.
MacFarlane DF, Pustelny BL, Goldberg LH. An assessment of the suitability of Mohs micrographic surgery in patients aged 90 years and older. Dermatol Surg. 1998;23:389–392.
Berman B, Flores F. The treatment of hypertrophic scars and keloids. Eur J Dermatol. 1998;8:591–595.
Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis guidelines from the American Heart Association. Circulation. 2007;116:1736–1754.
Scher K, Elston DM, Hedrick JA, Joseph WS, Maurer T, Murakawa GJ. Treatment options in the management of uncomplicated skin and skin structure infections. Cutis. 2005;75:3–23.
American Academy of Orthopaedic Surgeons Advisory Statement on Antibiotic Prophylaxis for Dental Patients with Total Joint Replacements. http://www.aaos.org/about/papers/advistmt/1027.asp. Last accessed January 21, 2009.
Wright TI, Baddour LM, Berbari EF. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol. 2008;59:464–473.
Sheridan RL, Schulz JT, Weber JM, et al. Cutaneous herpetic infections complicating burns. Burns. 2000;26:621–624.
Fidler PE, Mackool BT, Schoenfeld DA, et al. Incidence, outcome, and long-term consequences of herpes simplex virus type 1 reactivation presenting as a facial rash in intubated adult burn patients treated with acyclovir. J Trauma. 2002;53:86–89.
Verrill PJ. Adverse reactions to local anaesthetics and vasoconstrictor drugs. Practitioner. 1975;214: 380–387.
Amsler E, Flahault A, Mathelier-Fusade P, Aractingi S. Evaluation of re-challenge in patients with suspected lidocaine allergy. Dermatology. 2004;208:109–111.
Dire DJ. Hogan DE. Double-blinded comparison of diphenhydramine versus lidocaine as a local anesthetic. Ann Emerg Med. 1993;22:1419–1422.
Romano A, Gueant-Rodriguez RM, Viola M, Pettinato R, Gueant JL. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med. 2004;141:16–22.
El-Gamal HM, Dufresne RG, Saddler K. Electrosurgery, pacemakers, and ICDs: a survey of precautions and complications experienced by cutaneous surgeons. Dermatol Surg. 2001;27:385–390.
Lane JE, O’Brien EM, Kent DE. Optimization of thermocautery in excisional dermatologic surgery. Dermatol Surg. 2006;32:669–675.
Haines RC Jr, Brooks LR. Office space planning and design for medical practices, Part 1: an overview. J Med Pract Manage. 2003;18:244–249.
Haines RC Jr, Griffin JK. Office space planning and design for medical practices: Part 3, Implementation, design, and construction. J Med Pract Manage. 2003;19:19–26.
Lutz ME. Surgical pearl: curettage before cutaneous surgery to identify an unidentifiable biopsy site. J Am Acad Dermatol. 2002;46:591–593.
Robbins P, Sarnoff DS. Where’s the spot? J Dermatol Surg Oncol. 1986;12:1251–1252.
Futoryan T, Grande D. Postoperative wound infection rates in dermatologic surgery. Dermatol Surg. 1995;21:509–514.
Whitaker DC, Grande DJ, Johnson SS. Wound infection rate in dermatologic surgery. J Dermatol Surg Oncol. 1988;14:525–528.
Carmichael AJ, Flanagan PG, Holt PJA, Duerden BI. The occurrence of bacteraemia with skin surgery. Br J Dermatol. 1996;134:120–122.
Mulberry G, Snyder AT, Heilman J, Pyrek J, Stahl J. Evaluation of a waterless, scrubless chlorhexidine gluconate/ethanol surgical scrub for antimicrobial efficacy. Am J Infect Control. 2001;29:377–382.
Gupta C, Czubatyj AM, Briski LE, Malani AK. Comparison of two alcohol-based surgical scrub solutions with an iodine-based scrub brush for presurgical antiseptic effectiveness in a community hospital. J Hosp Infect. 2007;65:65–71.
Rhinehart BM, Murphy ME, Farley MF, Albertini JG. Sterile versus nonsterile gloves during Mohs micrographic surgery: infection rate is not affected. Dermatol Surg. 2006;32:170–176.
Kupres K, Rasmussen SE, Albertini JG. Perforation rates for nonsterile examination gloves in routine dermatologic procedures. Dermatol Surg. 2002;28:388–389.
Gross DJ, Jamison Y, Martin K, Fields M, Dinehart SM. Surgical glove perforation in dermatologic surgery. J Dermatol Surg Oncol. 1989;15:1226–1228.
Cohen MD, Do JT, Tahery DP, Moy RL. Efficacy of double gloving as a protection against blood exposure in dermatologic surgery. J Dermatol Surg Oncol. 1992;18:873–874.
Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: report of the American college of cardiology/American heart association task force on practice guidelines (committee on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol. 1996;27:910–948.
Chipev CC, Simon M. Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1. BMC Dermatol. 2002;2:13.
Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs. bacitracin ointment: a randomized controlled trial. JAMA. 1996;276:972–977.
Classen CD, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Eng J Med. 1992;326:281–286.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Stasko, T., Ross, A. (2009). Optimizing Surgical Outcomes. In: MacFarlane, D.F. (eds) Skin Cancer Management. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88495-0_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-88495-0_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-88494-3
Online ISBN: 978-0-387-88495-0
eBook Packages: MedicineMedicine (R0)